Sign in

Shelley G. Broader

Director at INSP
Board

About Shelley G. Broader

Shelley G. Broader, age 60, is a Class III independent director of Inspire Medical Systems and has served on the board since 2020. She chairs the Organization and Compensation Committee and sits on the Nominating and Corporate Governance Committee; she is considered independent under NYSE rules and attended all board and relevant committee meetings in FY 2024. She holds a B.A. from Washington State University and brings CEO experience and global consumer brand expertise from senior leadership roles at Chico’s FAS and Walmart.

Past Roles

OrganizationRoleTenureCommittees/Impact
Chico’s FAS, Inc.Chief Executive Officer and President2015–2019CEO leadership; retail consumer/brand management expertise
Walmart Inc. (Sam’s Club; Walmart Canada; EMEA region)SVP Sam’s Club; CMO Walmart Canada; CEO Walmart Canada; CEO EMEA (Europe, Middle East, Sub-Saharan Africa)2009–2015International/global operations leadership; consumer/brand strategy

External Roles

CompanyRoleTenureNotes
Loblaw Companies LimitedDirectorSince 2022Public company board service
Dutch Bros Inc.Director2021–2023Public company board service
Chico’s FAS, Inc.Director2015–2019Public company board service
Raymond James Financial, Inc.Director2008–2020Public company board service

Board Governance

  • Board classification: Inspire has a classified board (three classes) with staggered three-year terms; Broader is Class III with term expiring at the 2027 meeting.
  • Independence: Determined independent under NYSE rules (8 of 9 current directors are independent; CEO is not).
  • Committee assignments: Chair, Organization & Compensation; Member, Nominating & Corporate Governance.
  • Attendance and engagement: Board met 5x; O&C met 5x; NCG met 4x; each incumbent director attended all meetings of the Board and committees on which they served; all directors attended the 2024 annual meeting.
  • Lead Independent Director: Gary L. Ellis has served as Lead Director since 2024.
  • Executive sessions: Independent/non-management sessions are regularly scheduled, presided over by the Lead Director.

Fixed Compensation

ComponentAmountVesting/TermsFY 2024 Actual for Broader
Annual cash retainer (director)$50,000Paid quarterlyIncluded in $65,000 fees
Org & Comp Committee chair fee$15,000Paid quarterlyIncluded in $65,000 fees
NCG non-chair member fee$7,500Paid quarterlyNot applicable in 2024 (joined NCG Feb 2025)
Audit Committee chair/member fees$20,000 / $10,000Paid quarterlyNot applicable
Lead Director retainer$32,000Added May 2024Not applicable to Broader
QPST Committee chair/member fees$15,000 / $7,500Added Feb 2025Not applicable in 2024
Fees earned or paid in cash (total)$65,000FY 2024$65,000 (356 shares elected in lieu of cash)

Notes:

  • Payment election: Broader elected to receive a portion of cash fees in fully vested common stock (356 shares).

Performance Compensation

Equity TypeGrant ValueVestingTerms/Performance
Annual RSU grant (directors)$180,000Vests on first anniversary of grant dateSubject to service; accelerates on Change in Control under 2018 Plan
Initial RSU grant (new directors)$270,000Vests in 3 equal installmentsFor initial appointment; service-based
Options (non-employee directors)No stock options were granted to directors in 2024

Other Directorships & Interlocks

  • Compensation Committee interlocks: During 2024, the O&C Committee members (Broader, Burks, Tansey) were not officers; no executive officers served on other boards’ compensation committees; no interlock relationships requiring disclosure.
  • Consultant independence: The O&C Committee engaged Aon Human Capital Solutions; assessed as independent; no conflicts of interest; services included peer benchmarking and market analyses.

Expertise & Qualifications

  • Consumer Marketing/Brand Management (retail and brand leadership)
  • International/Global operations leadership
  • Chief Executive Officer experience (Chico’s FAS)

Equity Ownership

MetricValueAs-of DateNotes
Beneficial ownership (shares)8,123March 4, 2025Includes 5,531 shares underlying options exercisable within 60 days
Ownership % of outstanding<1%March 4, 2025Less than 1% of 29,759,651 shares outstanding
Exercisable options (≤60 days)5,531March 4, 2025Included in beneficial ownership
Unvested RSUs (year-end)716Dec 31, 2024Aggregate unvested RSUs as of FY-end
Pledged sharesNone disclosedMarch 4, 2025Anti-pledging policy prohibits pledging absent approval; CEO pledge disclosed, not Broader
Ownership guideline complianceIn complianceDec 31, 2024Directors must hold ≥3x annual cash retainer; all non-employee directors met guidelines as of 12/31/24 (except specified new execs)

Governance Assessment

  • Board effectiveness: As O&C Committee Chair, Broader oversees CEO and executive compensation, succession, ownership guidelines, and clawback policy, supported by an independent consultant (Aon). This points to structured pay governance aligned with performance.
  • Independence and engagement: Independent under NYSE rules with full meeting attendance; joined NCG in Feb 2025, expanding governance responsibilities.
  • Incentives and alignment: Director pay combines modest cash retainers with time-based RSUs; Broader elected stock in lieu of cash, increasing alignment. Ownership guidelines met; no pledging/hedging allowed.
  • Potential conflicts: No related-party transactions disclosed involving Broader; Company’s only disclosed related-person transaction involves cost-sharing for a suite with an entity controlled by the CEO, subject to Audit Committee policy.
  • Signals to investors: Strong say-on-pay support (97% in 2024) and robust committee structure (including quality/supply/technology oversight) suggest responsive governance; however, classified board, plurality voting, and supermajority provisions persist and may be viewed as entrenching mechanisms.

RED FLAGS: None identified specific to Broader (no attendance issues, pledging, or related-party transactions). Structural governance features (classified board, plurality standard, supermajority requirements) exist at the company level and may impact investor perceptions of board accountability.

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%